iX Biopharma Ltd. (SG:42C) has released an update.
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
iX Biopharma Ltd has announced a reduction in net proceeds from its Rights cum Warrants Issue to $1.55 million after a significant shareholder, Anson Properties, was unable to fulfill its subscription commitment due to timing of funds. Anson Properties still intends to invest in the company within the next four to six weeks. The company reassures that this event will not materially impact operations or finances and will keep the market updated through SGXNET.
For further insights into SG:42C stock, check out TipRanks’ Stock Analysis page.
